Enable Injections, Inc., a US-based company that develops and manufactures the enFuse platform of wearable drug delivery systems, announced on Wednesday that it has named David Kroekel as its new chief operating officer.

In the new role, the company says that Kroekel will play an important role in heading the ongoing engineering, manufacturing and supply of the firm's enFuse technology.

Kroekel has over 35 years of experience in medical device, combination product operations, and product development. He has served as the biomedical global head of operations at DSM Biomedical and as sr director of Innovation. He has served in various senior positions in the medical device industry for companies such as Flowonix Medical, Teleflex Medical, and Arrow International's EMEA business unit in Belgium.